The Valley Desk

NCT00025233 · Interventional trial

Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix

Overall registry status Completed

Phase 2

Conditions Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov